Publications in internationally indexed journals

• Feb - 2018

  ---

• Long-term effects of glucocorticoids on function, quality of life and survival in patients with Duchenne Muscular Dystrophy: a prospective cohort study; Lancet 2018; 391: 451-61.

• Nov - 2017

  ---

• Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database - J Neuromuscul Dis. 2017; 4(4): 293–306.

• Aug - 2017

  ---

• Interleukin 1 receptor-Like 1 protein (ST2) is a potential bio-marker for cardiomyopathy in Duchenne Muscular Dystrophy; Paediatric Cardiology 2017: 38: 1606-1612

• Nov - 2016

  ---

• Association study of exon variants in the NF-kb and TGF B pathwaysidentifies CD 40 as a modifier of Duchenne Muscular Dystrophy: American Journal of Human Genetics 2016: 99, 1163-1171

• Oct 2015

  ---

• Prednisolone / Prednisolone and Deflazocort regimens in the CINRG Duchenne natural history study, Neurology 2015;85:1048-1055.

• Jan 2015

  ---

• The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations. HUMAN MUTATION, Vol. 36, No. 4, 395–402, 2015

• Aug 2014

  ---

• CINRG Duchenne Natural History study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne Muscular Dystrophy;Muscle and Nerve 2014: 50 (2): 250-256

• Aug 2013

  ---

• The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia : Bladen,C. L., Rafferty, K., Straub, V., Monges, S., Moresco, A., Dawkins, H., Roy, A., Chamova, T., Guergueltcheva, V., Korngut, L., Campbell, C., Dai, Y., Barišić, N., Kos, T., Brabec, P., Rahbek, J., Lahdetie, J., Tuffery-Giraud, S., Claustres, M., Leturcq, F., Ben Yaou, R., Walter, M. C., Schreiber, O., Karcagi, V., Herczegfalvi, A., Viswanathan, V., Bayat, F., de la caridad Guerrero Sarmiento, I., Ambrosini, A., Ceradini, F., Kimura, E., van den Bergen, J. C., Rodrigues, M., Roxburgh, R., Lusakowska, A., Oliveira, J., Santos, R., Neagu, E., Butoianu, N., Artemieva, S., Rasic, V. M., Posada, M., Palau, F., Lindvall, B., Bloetzer, C., Karaduman, A., Topaloğlu, H., Inal, S., Oflazer, P., Stringer, A., Shatillo, A. V., Martin, A. S., Peay, H., Flanigan, K. M., Salgado, D., von Rekowski, B., Lynn, S., Heslop, E., Gainotti, S., Taruscio, D., Kirschner, J., Verschuuren, J., Bushby, K., Béroud, C. and Lochmüller, H. (2013),. Hum. Mutat., 34: 1449–1457.

• May 2013

  ---

• cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used, McDonald CM1, Henricson EK, Abresch RT, Han JJ, Escolar DM, Florence JM, Duong T, Arrieta A, Clemens PR, Hoffman EP, Cnaan A; Cinrg Investigators – Viswanathan V - Muscle Nerve. 2013,Jul;48(1):32-54.

• Feb 2011

  ---

• Randomized, blinded trial of weekend versus daily prednisone in Duchenne muscular dystrophy, Diana M. Escolar, Lauren P. Hache, Paula R. Clemens, Avital Cnaan, Craig M.McDonald, Venkataraman Viswanathan, Andrew Kornberg, Tulio E. Bertorini, Yoram Nevo, Timothy Lotze, Alan Pestronk, Monique Ryan, Eugenio Monasterio, John W.Day, Angela Zimmerman, Adrienne Arrieta, Erik Henricson, Jill Mayhew, Julaine Florence, Fengming Hu, and Anne Connolly, Neurology – 2011Aug 2;77(5):444-52.

• Apr 2008

  ---

• Randomized double-blind controlled study to compare efficacy and tolerability of standard daily prednisone regime with a novel intermittent high dose regime in ambulant boys with Duchenne Muscular Dystrophy (DMD). Escolar, DM, McDonald, C, Viswanathan, V, Korenberg, AJ, Bertorini, TE, Nevo, Y, Lotze, TE, Ryan, M, Clemens, PR, Monasterio, E, Leshner, RT , Pestronk, A, Morgenroth, LP, Zimmerman, A, Arrieta, A, Abresh, T, Henricson, E, Mayhew, J, Florence, JM; Duong, T, Hu, F, Nei, L, McCarter, R, Connolly, A, and the CINRG group presented at the American Academy of Neurology Conference in April 2008.